Sikes-Keilp, Christopher https://orcid.org/0000-0002-4337-1229
Rubinow, David R.
Article History
Received: 10 August 2021
Accepted: 8 October 2021
First Online: 18 October 2021
Declarations
:
: Not applicable; this article is a review only and did not involve human participants, human data, human tissue, or animal subjects.
: Not applicable.
: Dr. Rubinow is on the Clinical Advisory Board of (and has received honoraria and stock options from) Sage Therapeutics. He is also on the Scientific Advisory Boards of Terran BioSciences and Sensorium Therapeutics. Dr. Sikes-Kelp reports no conflicts of interest. The authors declare that they have no competing interests.